
The CAROLINA cardiovascular safety study found that linagliptin was non-inferior to glimepiride in time to a composite cardiovascular endpoint.

The CAROLINA cardiovascular safety study found that linagliptin was non-inferior to glimepiride in time to a composite cardiovascular endpoint.

A 300,000-plus patient cohort analysis showed patients with atherosclerotic cardiovascular disease are at a significantly greater risk of death if they don't adhere to statin prescriptions.

Since 2016, the health system has practiced a heart failure readmission reduction program that's improving patient quality of life.

The organization has provided five-year updates to its recommendation of therapies for adults with pulmonary arterial hypertension.

Investigators suggest the findings mean anticoagulants or antiplatelets could potentially treat migraine patients with aura.

Patients with influenza-like illness face a higher risk of stroke up to a year after infection.

Investigators identified a correlation between infection with high-risk strains of HPV and increased risk of cardiovascular disease, especially among women with obesity or metabolic syndrome.

A systematic review and meta-analysis of nearly 10,000 patients found systolic AOBP readings, under the right circumstances, should become the standard blood pressure test.

Heart patients discharged from the hospital with an opioid prescription were less likely to participate in planned follow-up care than those without prescribed opioids.

Largest observational study on antiepileptic treatment for poststroke epilepsy finds highest adherence to a less frequently prescribed drug.

Atrial fibrillation recurrence remains a challenge amidst significant advances in managing stroke risk. Could the CHA2DS2-VASc score help?

Exposure to excessive heat, especially during early pregnancy, is expected to drive an increase in congenital heart defects.

Inner-city African-American patients are 5 times more likely to have hypertensive emergency, according to a recent study.

According to updated statistics form the American Heart Association (AHA), cardiovascular disease is present in approximately 50% of US adults.

Updates to the atrial fibrillation guidelines now recommend a newer type of blood-thinning medication called non-vitamin K oral anticoagulants (NOACs).

In the past 5 years, the administration has continually improved on the previous year's rate. More of the same should be anticipated in 2019.

The SPRINT MIND study did find that intensive treatment reduced the risk of mild cognitive impairment, a precursor to dementia.

About 1 in 7 heart failure patients have COPD, which can lead to a 30% increase in risk of hospitalization and death.

The TactiCath Contact Force Ablation Catheter is used for cardiac ablation procedures.

Statins are already a common therapy among patients with type 2 diabetes. Its cholesterol-lowering benefits may help retain patient vision longer.

The FDA has approved Verily’s Study Watch, a wearable medical device that conducts electrocardiograms (ECGs).

The hypertension medication is again being recalled due to carcinogenic impurities.

Coronary artery disease remains the top killer of Americans—these tools may help identify people who are still at risk.

The FDA has responded to the Janssen Pharmaceutical company's sNDA with a request for more data.

Improvements in muscle and cardiac function were observed for 18 months in tested mice.